Brain MRI findings in patients with Fabry disease

Journal of the Neurological Sciences

Volumn 305, Issue 1-2, 2011, Pages 41-44

  Reisin, Ricardo C ^a   Romero, Carlos ^b   Marchesoni, Cintia ^a   Nápoli, Gabriel ^a   Kisinovsky, Isaac ^c   Cáceres, Guillermo ^d   Sevlever, Gustavo ^b  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^b FLENI   (Argentina)

^c Instituto Médico Quilmes   (Argentina)

^d Hospital Comunitario de Pinamar   (Argentina)

Author keywords

Cerebral infarct; Fabry disease; GRE; Microbleeds; MRI; Stroke

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BRAIN STEM; CLINICAL ARTICLE; CORONA RADIATA (BRAIN); FABRY DISEASE; FEMALE; GRAY MATTER; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STROKE; THALAMUS; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

ADOLESCENT; ADULT; AGED; BASAL GANGLIA; BRAIN ISCHEMIA; BRAIN STEM; CHILD; COMORBIDITY; FABRY DISEASE; FEMALE; HUMANS; INTERNAL CAPSULE; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; THALAMUS; YOUNG ADULT;

EID: 79955685377     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2011.03.020     Document Type: Article

References (36)

1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl JMed 1967;276:1163-7.
2. Zarate A, Hopkin RJ. Fabry's disease. Lancet 2008;372:1427-35.
3. Clarke JT. Narrative review: Fabry disease. Ann Intern Med 2007;146:425-33. (Pubitemid 351650579)
4. Mehta A, Clarke JT, Giugliani R, Elliott P, Linhart A, Beck M, et al. Natural course of Fabry disease: changing pattern of causes of death in FOS-Fabry Outcome Survey. J Med Genet 2009;46:548-52.
5. Sims K, Politei J, Banikazemi M, Lee P. Stroke in Fabry Disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 2009;40:788-94.
6. Schiffmann R. Fabry Disease. Pharmacol Ther 2009:122:65-77.
7. Rolfs A, Böttcher T, Zschiesche M, Morris P, Winchester B, Bauer P, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005;366:1794-6. (Pubitemid 41642643)
8. Wozniak MA, Kittner SJ, Tuhrim S, Cole JW, Stern B, Dobbins M, et al. Frequency of unrecognized Fabry Disease among young European-American and African-American Men with first ischemic stroke. Stroke 2010;41:78-81.
9. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-74.
10. Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, et al. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 1998;50:1746-9. (Pubitemid 28283245)
11. Buechner S, Moretti M, Burlina AP, Cei G, Manara R, Ricci R, et al. Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry 2008;79:1249-54.
12. Ginsberg L, Manara R, Valentine AR, Kendall B, Burlina AP. Magnetic resonance imaging changes in Fabry disease. Acta Paediatr Suppl 2006;95:57-62. (Pubitemid 43739097)
13. Fellgiebel A, Müller MJ, Mazanek M, Baron K, Beck M, Stoeter P. White matter lesion severity in male and female patients with Fabry disease. Neurology 2005;65:600-2. (Pubitemid 41170723)
14. AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales). Evaluation of patients with Fabry disease in Argentina. Med B Aires 2010;70:37-43.
15. Whybra C, Kampmann C, Krummenauer F, Ries M, Mengel E, Miebach E, et al. The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 2004;65:299-307. (Pubitemid 38443553)
16. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-22. (Pubitemid 32530416)
17. Burlina AP, Manara R, Caillaud C, Laissy JP, Severino M, Klein I, et al. The pulvinar sign: frequency and clinical correlations in Fabry disease. J Neurol 2008;255:738-44.
18. Kaye EM, Kolodny EH, Logigian EL, Ullman MD. Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 1988;23:505-9.
19. Cabrera-Salazar MA, O'Rourke E, Charria-Ortiz G, Barranger JA. Radiological evidence of early cerebral microvascular disease in young children with Fabry disease. J Pediatr 2005;147:102-5. (Pubitemid 40981153)
20. Jardim L, Vedolin L, Schwartz IV, Burin MG, Cecchin C, Kalakun L, et al. CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. J Inherit Metab Dis 2004;27:229-40. (Pubitemid 38756339)
21. Bass BH. Angiokeratoma corporis diffusum. Br Med J 1958;1:1418 (Letter).
22. Wise D, Wallace HJ, Jellinek EH. Angiokeratoma corporis diffusum. A clinical study of eight affected families. Q J Med 1962;31:177-206.
23. Wallace RD, Cooper WJ. Angiokeratoma corporis diffusum universal (Fabry). Am J Med 1965;39:656-61.
24. Nakamura K, Sekijima Y, Nakamura K, Hattori K, Nagamatsu K, Shimizu Y, et al. Cerebral hemorrhage in Fabry's disease. J Hum Genet 2010;55:259-61.
25. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995;333:288-93.
26. Offenbacher H, Fazekas F, Schmidt R, Koch M, Fazekas G, Kapeller P. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996;17:573-8. (Pubitemid 26101967)
27. Lee SH, Bae HJ, Kwon SJ, Kim H, Kim YH, Yoon BW, et al. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004;62:72-6. (Pubitemid 38082873)
28. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004;35:1415-20. (Pubitemid 38697468)
29. Wong KS, Chan YL, Liu JY, Gao S, Lam WW. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology 2003;60:511-3. (Pubitemid 36188256)
30. Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology 2009;72:171-6.
31. Nighoghossian N, Hermier M, Adeleine P, Blanc-Lasserre K, Derex L, Honnorat J, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke 2002;33:735-42. (Pubitemid 34204000)
32. Fan YH, Zhang L, Lam WW, Mok VC, Wong KS. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003;34:2459-62. (Pubitemid 37221963)
33. Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006;66:165-71.
34. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR 1999;20:637-42. (Pubitemid 30429021)
35. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008;70:1208-14. (Pubitemid 351482572)
36. Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 1999;30:1637-42. (Pubitemid 29379616)